AP
CO

AHL Partners’s Global Cord Blood Corporation CO Stock Holding History

AHL Partners’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-45,298
Closed -$504K – 1435
2017
Q3 		$504K Buy
+45,298
New +$530K 0.01% 1048

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

AHL Partners's CO Position: Q4 2017 in Review

AHL Partners sold out of Global Cord Blood Corporation (CO) in Q4 2017, closing a stake of 45,298 shares — an estimated $504K sold.

AHL Partners first reported a position in CO in Q3 2017 and held it in 1 quarter. The position peaked at $504K in Q3 2017. 50 funds tracked by Wall St. Rank hold CO as of Q4 2017.

  • AHL Partners reported no remaining Global Cord Blood Corporation position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 45,298 Global Cord Blood Corporation shares in Q4 2017, an estimated $504K.
  • AHL Partners first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 1 quarter.
  • AHL Partners's Global Cord Blood Corporation position peaked at $504K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.